课题基金 / 基金详情

Molecular Genetical and Functional Analysis in Insulin Receptor Gene Mutation

Molecular Genetical and Functional Analysis in Insulin Receptor Gene Mutation
胰岛素受体基因突变的分子遗传学和功能分析
批准号:
03671131
负责人:
MAKINO Hideichi
金额:
$1.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

MAKINO Hideichi的其他基金

相似基金

相关文献

中文摘要
翻译
非胰岛素依赖型糖尿病(NIDDM)表现为轻度至中度的胰岛素抵抗,但在某些遗传综合征中也有严重胰岛素抵抗的报道。为了了解胰岛素抵抗在NIDDM中的机制,首先分析这些综合征的胰岛素抵抗机制是有用的。我们确定了四个胰岛素受体基因突变,并分析了这些病例中糖尿病的发展。A型千叶在第17-22外显子有缺失突变,A型山梨在第14外显子有缺失突变,A型北海道-2在第1008位氨基酸处有一点突变,由瓦尔取代Gly。Leprechaun/Asahi在一个等位基因中的外显子15中存在两个碱基对缺失,另一个等位基因中存在低mRNA突变。在家系和临床分析中,酪氨酸激酶结构域中的单个突变等位基因,如A型千叶和A型北海道-2,显示糖尿病的显性表达,但跨膜结构域中的一个,如A型山梨没有。这两个等位基因的突变,如Lep/Asahi,表现出严重的胰岛素抵抗形式,如矮妖精病。
英文摘要
Non-insulin-dependent diabetes mellitus (NIDDM) shows mild to moderate insulin resistance, but severe insulin resistance has been reported in some genetic syndromes. In order to understand the mechanism of insulin resistance in NIDDM, it is useful to first analyze this mechanism in these syndromes. We have identified four mutations in insulin receptor gene and analyzed the development of diabetes in these cases. Type A Chiba had deletion mutation in exon 17-22, Type A Yamanashi showed deletion of exon 14 and Type A Hokkaido-2 had a point mutation substituting Val for Gly in the 1008th amino acids in respective one allele. Leprechaun/Asahi showed two base pair deletion in exon 15 in one allele and low mRNA mutation in the other allele. In the pedigree and clinical analysis, a single mutant allele in the tyrosine kinase domain, such as Type A Chiba and Type A Hokkaido-2 showed dominant expression of diabetes, but the one in the transmembrane domain, such as Type A Yamanashi did not. The mutation in both alleles, such as Lep/Asahi showed severe forms of insulin resistance, such as leprechaunism.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
Makino H, Taira M, Shimada F, Hashimoto N, Suzuki Y, Nozaki O, Hatanaka Y, Yoshida S: "Insulin receptor gene mutation: a molecular genetical and functional analysis." Cellular Signaling. 4. 351-363 (1992)
Makino H、Taira M、Shimada F、Hashimoto N、Suzuki Y、Nozaki O、Hatanaka Y、Yoshida S:“胰岛素受体基因突变:分子遗传学和功能分析。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohsawa H, Kanatsuka A, Tokuyama Y, Yamaguchi T, Makino H, Yoshida S, Horie H, Mikata A, Kohen Y: "Amyloid protein in somatostatinoma differs from human islet amyloid polypeptide." Acta Endocrinologica. 124. 45-53 (1991)
Ohsawa H、Kanatsuka A、Tokuyama Y、Yamaguchi T、Makino H、Yoshida S、Horie H、Mikata A、Kohen Y:“生长抑素瘤中的淀粉样蛋白不同于人胰岛淀粉样多肽。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
牧野 英一: "インスリンレセプタ-と糖尿病ーレセプタ-遺伝子欠失の2家系" 医学のあゆみ, (156)990-994 (1991)
Eiichi Makino:“胰岛素受体和糖尿病受体基因缺失的两个家族”医学史,(156)990-994(1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
牧野 英一、平良 真人、島田 典生、橋本 尚武、鈴木 義史、野崎 修、畑中 幸子、吉田 尚: "治寮学" (1992)
牧野荣一、平良正人、岛田纪男、桥本尚武、铃木芳文、野崎修、畠中幸子、吉田恒:“次陵研究”(1992)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 23 条
    The cloning and characterization of the 50 kDa protein which is associated with PDE3B and phosphorylated by insulin
    • 批准号:
      17590939
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2005
    • 负责人:
      MAKINO Hideichi
    • 依托单位:
    Whole genome association study on type 2 diabetes susceptibility genes using microsatellite markers and DNA pool
    • 批准号:
      14571096
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.79万
    • 财政年份:
      2002
    • 负责人:
      MAKINO Hideichi
    • 依托单位:
    Analysis of insulin-induced PDE kinase activation by gene transfer using adenovirus vector
    • 批准号:
      11671122
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1999
    • 负责人:
      MAKINO Hideichi
    • 依托单位:
    cDNA and Genomic Cloning of Human Insulin-sensitive Phosphodiesterase.
    • 批准号:
      05670840
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1993
    • 负责人:
      MAKINO Hideichi
    • 依托单位:
    海外基金